Hepatitis News : Risk Factors for Low Platelets in People With HIV
A Smart + Strong Site
Subscribe to:
Hepatitis E-newsletter
Join Us:

Back to home » Hepatitis News » September 2009


emailprint

September 8, 2009

Risk Factors for Low Platelets in People With HIV

Hepatitis C virus (HCV) infection, severe liver damage and uncontrolled HIV replication are all associated with a greater risk for low platelets in people with HIV, according to a study published online September 3 in the Journal of Acquired Immune Deficiency Syndromes.

Thrombocytopenia, the technical term for too few platelets, was once quite common in people living with HIV. Having a low platelet count means that the blood has a harder time forming clots, which amplifies the chance of bruising and excessive bleeding—increasing the risk of stroke in severe cases. The incidence of thrombocytopenia since the introduction of potent three-drug combination HIV therapy is not well known, though it has dropped.

To determine the likelihood of developing thrombocytopenia, Kristen Marks, MD, MS, and her colleagues from Weill Cornell Medical College in New York City, compared 73 people with HIV who were diagnosed with thrombocytopenia with 73 people with HIV who did not have the condition. The two groups were matched based on age, sex and other health factors, such as using drugs that can cause low platelet counts. The average age was 41; about half of the participants were female; and just over half had a CD4 count greater than 200.

Marks and her colleagues found that HCV infection—particularly uncontrolled HCV infection and advanced liver disease—made someone far more likely to have thrombocytopenia. Interestingly, uncontrolled HIV infection was also highly associated with low platelets, regardless of a person’s CD4 count or previous AIDS diagnosis.

The authors conclude that people with HCV and HIV coinfection should be monitored carefully for low platelets, as even mild thrombocytopenia can result in internal bleeding. Thrombocytopenia should also be carefully considered when deciding whether to start interferon-based HCV treatment because that drug can contribute to low platelet counts. Marks’s team also comments that the majority of thrombocytopenia cases in people without HCV or liver damage are likely a result of uncontrolled HIV replication; the authors note that further research will be necessary to understand why this is the case.

Search: thormbocytopenia, platelets, bleeding, bruising, Kristen Marks, hepatitis C virus, HCV, liver damage


Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (2 total)


[Go to top]

Quick Links
Current Issue
Forums
Poll
Blogs
Hep TV
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Are you planning to do anything for World Hepatitis Day on July 28?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.